Bio-Techne
TECH
$62.34
Share price
-1.86%
Change (1 day)
-25.87%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - Total debt
Total debt on the balance sheet as of December 2023 : $0.55 B
According to Bio-Techne's latest financial reports the company's total debt is $0.55 B. A company’s total debt is the sum of all current and non-current debts.
Bio-Techne - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-06-30 | $0.45 B | 39.57% |
| 2022-06-30 | $0.32 B | -22.49% |
| 2021-06-30 | $0.42 B | -2.99% |
| 2020-06-30 | $0.43 B | -14.18% |
| 2019-06-30 | $0.50 B | 49.01% |
| 2018-06-30 | $0.33 B | -1.39% |
| 2017-06-30 | $0.34 B | 260.88% |
| 2016-06-30 | $95.25 M | 23.67% |
| 2015-06-30 | $77.02 M | 494.96% |
| 2014-06-30 | $12.94 M | |
| 2006-06-30 | $13.42 M | -8.13% |
| 2005-06-30 | $14.61 M | -7.83% |
| 2004-06-30 | $15.85 M | -7.19% |
| 2003-06-30 | $17.08 M | -5.34% |
| 2002-06-30 | $18.05 M | -4.67% |
| 2001-06-30 | $18.93 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 6,183.44% | 🇺🇸 USA |
 Becton Dickinson BDX | $16.11 B | 2,799.05% | 🇺🇸 USA |
 General Electric GE | $22.93 B | 4,027.59% | 🇺🇸 USA |
 Danaher DHR | $19.53 B | 3,415.57% | 🇺🇸 USA |
 Qiagen QGEN | $1.53 B | 175.70% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $7.18 M | -98.71% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $1.40 B | 152.91% | 🇺🇸 USA |